|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2024―Mrz―07 |
Post-acute sequelae of SARS-CoV-2 infection in health care workers from South Africa |
Sthembile Mbotwe-Sibanda, Gaurav Kwatra, Shabir A Madhi, Marta C Nunes |
2 |
[GO] |
2023―Mrz―08 |
Autoimmunity in Long Covid and POTS |
Fatema-Zahra El-Rhermoul, Artur Fedorowski, Philip Eardley, Patricia Taraborrelli, Dimitrios Panagopoulos, Richard Sutton, et al. (+2) Phang Boon Lim, Melanie Dani |
3 |
[GO] |
2023―Jan―19 |
Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2 |
Kriti Negi, Meetu Agarwal, Isha Pahuja, Bhavya Bhardwaj, Mansi Rawat, Ashima Bhaskar, Ved Prakash Dwivedi |
4 |
[GO] |
2023―Jan―03 |
Endogenous antibody responses in REGN-COV2 treated SARS-CoV-2 infected individuals |
Ashwini Kurshan, Luke Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, et al. (+3) Jonathan D Edgeworth, Gaia Nebbia, Katie J Doores |
5 |
[GO] |
2022―Sep―27 |
Long Covid brain fog: a neuroinflammation phenomenon? |
Emma Kavanagh |
6 |
[GO] |
2022―Sep―15 |
Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity |
Simon Haunhorst, Wilhelm Bloch, Heiko Wagner, Claudia Ellert, Karsten Krüger, Daniel C Vilser, et al. (+5) Kathrin Finke, Philipp Reuken, Mathias W Pletz, Andreas Stallmach, Christian Puta |
7 |
[GO] |
2022―Aug―17 |
SARS-CoV-2 immunity and vaccine strategies in people with HIV |
Claire Mullender, Kelly A S da Costa, Aljawharah Alrubayyi, Sarah L Pett, Dimitra Peppa |
8 |
[GO] |
2022―Jun―20 |
The past, current and future epidemiological dynamic of SARS-CoV-2 |
François Balloux, Cedric Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala Maini, Lucy van Dorp |
9 |
[GO] |
2021―Mai―21 |
Overview of approved and upcoming vaccines for SARS-CoV-2: a living review |
Jennifer Alderson, Vicky Batchelor, Miriam O’Hanlon, Liliana Cifuentes, Felix Clemens Richter, Jakub Kopycinski |
10 |
[GO] |
2021―Feb―23 |
The T cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective role |
Antonio Bertoletti, Anthony T Tan, Nina Le Bert |
11 |
[GO] |
2021―Jan―28 |
The Role and Uses of Antibodies in COVID-19 Infections: A Living Review |
D Oliver Scourfield, Sophie G Reed, Max Quastel, Jennifer Alderson, Valentina M T Bart, Alicia Teijeira Crespo, et al. (+4) Ruth Jones, Ellie Pring, Felix Clemens Richter, Stephanie E A Burnell |
12 |
[GO] |
2021―Jan―26 |
Mucosal immune responses in COVID-19 |
Claire F Pearson, Rebecca Jeffery, Emily E Thornton |
13 |
[GO] |
2021―Jan―22 |
Impact of obesity on host defences: Implications for SARS-CoV-2 infection |
Felix Clemens Richter, Aljawharah Alrubayyi, Alicia Teijeira Crespo, Sarah Hulin-Curtis |
14 |
[GO] |
2020―Dez―29 |
T cell phenotypes in COVID-19 |
Stephanie J Hanna, Amy S Codd, Ester Gea-Mallorqui, D Oliver Scourfield, Felix C Richter, Kristin Ladell, et al. (+11) Mariana Borsa, Ewoud B Compeer, Owen R Moon, Sarah A E Galloway, Sandra Dimonte, Lorenzo Capitani, Freya R Shepherd, Joseph D Wilson, Lion F K Uhl, Awen M Gallimore, Anita Milicic |
15 |
[GO] |
2020―Dez―09 |
Innate immunology in COVID-19 - A LIVING REVIEW PART I: Viral entry, sensing and evasion |
Clarissa Coveney, Michel Tellier, Fangfang Lu, Shayda Maleki Toyserkani, Ruth Jones, Valentina M T Bart, et al. (+8) Ellie Pring, Aljawharah Alrubayyi, Felix C Richter, D Oliver Scourfield, Jan Rehwinkel, Patrícia R S Rodrigues, Luke C Davies, Ester Gea-Mallorquí |
16 |
[GO] |
2020―Dez―09 |
Innate immunology in COVID-19 - A LIVING REVIEW PART II: Dysregulated inflammation drives immunopathology |
Patrícia R S Rodrigues, Aljawharah Alrubayyi, Ellie Pring, Valentina M T Bart, Ruth Jones, Clarissa Coveney, et al. (+7) Fangfang Lu, Michel Tellier, Shayda Maleki-Toyserkani, Felix C Richter, D Oliver Scourfield, Ester Gea-Mallorquí, Luke C Davies |
17 |
[GO] |
2020―Jul―09 |
Adaptive immunity to SARS-CoV-2 |
Daniel M Altmann |
18 |
[GO] |
2020―Jun―17 |
Cholesterol-modifying drugs in COVID-19 |
Nathalie M Schmidt, Peter A C Wing, Jane A McKeating, Mala K Maini |